These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 563206)

  • 1. [Thromboembolic disease of long standing with hyperfibrinogenemia. Treatment with heparin, magnesium and anti-inflammatory agent].
    Cristau P; Hainaut J; Molinie C; Essioux H; Pariente A; Florent C; Laverdant C
    Ann Med Interne (Paris); 1977 Nov; 128(11):887-94. PubMed ID: 563206
    [No Abstract]   [Full Text] [Related]  

  • 2. [Esfar in an ENT department].
    Traissac L; Pasquet J
    Rev Laryngol Otol Rhinol (Bord); 1976; 97(3-4):177-9. PubMed ID: 1034331
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of a new anti-inflammatory agent, bucloxic acid, in the treatment of chronic glomerular nephropathies.
    Lagrue G; Masbernard A; Giudicelli C; Hirbec G
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1434-9. PubMed ID: 4614821
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences with Calciparin, a new subcutaneously injectable heparin preparation].
    Sessner HH; Brockhaus W; Kunzmann G; Stingl J
    Med Welt; 1971 Jan; 5():187-91. PubMed ID: 5546024
    [No Abstract]   [Full Text] [Related]  

  • 5. [Criteria of treatment in the intravascular coagulation syndrome in children].
    Chipail A; Schneer JH
    Pediatria (Bucur); 1971; 20(5):457-62. PubMed ID: 5166666
    [No Abstract]   [Full Text] [Related]  

  • 6. [Heparin treatment of thromboembolic complications].
    Samama M; Kher A; Horellou MH; Conard J
    Agressologie; 1983 Nov; 24(10):495-500. PubMed ID: 6367509
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of heparin therapy: sensitivity of the various methods].
    Merino J; González-Boullosa R; Benet I; García-Conde J
    Rev Clin Esp; 1978 Oct; 151(2):107-11. PubMed ID: 740979
    [No Abstract]   [Full Text] [Related]  

  • 8. [Importance of heparin in infants with consumption coagulation disease caused by septicemia].
    de Aquino-Jaso ME; Olvera-Hidalgo C; Ramírez JI
    Bol Med Hosp Infant Mex; 1974; 31(1):73-84. PubMed ID: 4433389
    [No Abstract]   [Full Text] [Related]  

  • 9. [Heparin therapy in the disseminated intravascular coagulation syndrome. Considerations on 2 cases].
    Cutcudache C; Pavelescu I; Brăilescu G; Bălan A; Boldescu G; Lachi D
    Med Interna (Bucur); 1971 Jun; 23(6):729-40. PubMed ID: 5565661
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of a new anti-inflammatory agent in the field of otorhinolaryngology].
    Roux O
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1975 Sep; 24(7):545-7. PubMed ID: 129512
    [No Abstract]   [Full Text] [Related]  

  • 11. [Salivary gland involvement during various anti-inflammatory treatments. Apropos of 2 cases].
    Verliac F; Calamy G; Palangié A; Bastin R
    Ann Med Interne (Paris); 1976 AUG-SEP; 127(8-9):561-5. PubMed ID: 1034456
    [No Abstract]   [Full Text] [Related]  

  • 12. [A new anti-inflammatory agent: calcium bucloxate in pediatrics].
    Debray H; Galland A
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1440-2. PubMed ID: 4548650
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biological surveillance during a test of 804 CB in internal medicine. 120 observations].
    Gallais H; Casanova P
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1442-4. PubMed ID: 4480073
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experimentation of calcium bucloxate (804 CB) in rheumatology].
    Louyot P; Tamisier JN; Pourel J
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1428-31. PubMed ID: 4614820
    [No Abstract]   [Full Text] [Related]  

  • 15. Heparin treatment of intravascular coagulation accompanying hemolytic transfusion reactions.
    Rock RC; Bove JR; Nemerson Y
    Anesth Analg; 1970; 49(2):231-5. PubMed ID: 4996107
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results of clinical trials of calcium bucloxate (804 CB) in rheumatology].
    de Sèze S; Dryll A; Dreiser R
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1425-8. PubMed ID: 4614819
    [No Abstract]   [Full Text] [Related]  

  • 17. [Resuscitation of patients with high risk of hemorrhage and thromboembolism. Biological supervision. Indications of controlled heparin therapy].
    Boneu B; Cathala B; Jorda MF; Bierme R; Lareng L
    Nouv Presse Med; 1972 Jan; 1(1):29-32. PubMed ID: 5061187
    [No Abstract]   [Full Text] [Related]  

  • 18. Sources of error in heparin therapy of thromboembolic disease.
    Hattersley PG; Mitsuoka JC; King JH
    Arch Intern Med; 1980 Sep; 140(9):1173-5. PubMed ID: 7406615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of 804 CB and phenylbutazone. Double blind test of venous and arterial pathology].
    Beurey J; Weber M; Toussain P; Jacob M
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1432-4. PubMed ID: 4480072
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnosis of acute acquired defects of coagulation and their therapy (author's transl)].
    Göbel EA
    Anaesthesist; 1976 Sep; 25(9):449-53. PubMed ID: 970600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.